Bioequivalence of Oral Clindamycin Phosphate Tablets in Healthy Volunteers

魏振满,丁晋彪,贺江平,张月梅,刘会臣,张丹,国书会
DOI: https://doi.org/10.3969/j.issn.1008-9926.2010.01.10
2010-01-01
Abstract:Objective To study the bioavailability and bioequivalence of the tested and reference clindamycin phosphate tablets in healthy male volunteers.Methods According to the crossover design,each volunteer was orally given 300 mg Clindamycin Phosphate Tablets.The plasma concentrations was determined by Liquid Chromatography/tandem Mass Spectrometry.Pharmacokinetic parameters was obtained using DAS program.Results Cmax was(2.896±1.007)μg/ml and(3.009 ±0.755)μg/ml,Tmax was(2.11±0.96)h and(1.89±0.92)h,T1/2 was(1.94±0.39)h and(1.86±0.30)h,AUC0–tnwas(12.625±4.956)μg·h/ml and(11.658±3.829) μg·h/ml,AUC0-∞ was(13.027±5.323) and(11.948±4.057) μg·h/ml,respectively.The relative bioavailability was(107.8±17.4)%.The data on the reference and tested drugs were not different as shown by F test.Conclusion The two Clindamycin Phosphate tablets made by two different pharmacies are bioequivalent.
What problem does this paper attempt to address?